<DOC>
	<DOCNO>NCT02269995</DOCNO>
	<brief_summary>This surveillance 's objective : 1 . Unknown adverse reaction 2 . Incidences adverse drug reaction 3 . Factors consider effect safety effectiveness</brief_summary>
	<brief_title>Post-marketing Surveillance DC Bead Patients With Hepatocellular Carcinoma</brief_title>
	<detailed_description />
	<mesh_term>Carcinoma</mesh_term>
	<mesh_term>Carcinoma , Hepatocellular</mesh_term>
	<criteria>Inclusion criterion : Patients Hepatocellular carcinoma Exclusion criterion :</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Hepatocellular</keyword>
	<keyword>Carcinoma</keyword>
</DOC>